{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:24:46Z","timestamp":1774959886106,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0010358","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000}}],"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UK Foreign, Commonwealth and Development Office and Wellcome","award":["215685\/Z\/19\/Z"],"award-info":[{"award-number":["215685\/Z\/19\/Z"]}]},{"name":"UK Foreign, Commonwealth and Development Office and Wellcome","award":["215685\/Z\/19\/Z"],"award-info":[{"award-number":["215685\/Z\/19\/Z"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ORIP grant S10OD028685"],"award-info":[{"award-number":["ORIP grant S10OD028685"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A global stockpile of oral cholera vaccine (OCV) was established in 2013 for use in outbreak response and are licensed as two-dose regimens. Vaccine availability, however, remains limited. Previous studies have found that a single dose of OCV may provide substantial protection against cholera.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a mathematical model with two age groups paired with optimization algorithms, we determine the optimal vaccination strategy with one and two doses of vaccine to minimize cumulative overall infections, symptomatic infections, and deaths. We explore counterfactual vaccination scenarios in three distinct settings: Maela, the largest refugee camp in Thailand, with high in- and out-migration; N\u2019Djamena, Chad, a densely populated region; and Haiti, where departments are connected by rivers and roads.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over the short term under limited vaccine supply, the optimal strategies for all objectives prioritize one dose to the older age group (over five years old), irrespective of setting and level of vaccination coverage. As more vaccine becomes available, it is optimal to administer a second dose for long-term protection. With enough vaccine to cover the whole population with one dose, the optimal strategies can avert up to 30% to 90% of deaths and 36% to 92% of symptomatic infections across the three settings over one year. The one-dose optimal strategies can avert 1.2 to 1.8 times as many cases and deaths compared to the standard two-dose strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In an outbreak setting, speedy vaccination campaigns with a single dose of OCV is likely to avert more cases and deaths than a two-dose pro-rata campaign under a limited vaccine supply.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0010358","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T13:35:31Z","timestamp":1650461731000},"page":"e0010358","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling study"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9075-4134","authenticated-orcid":true,"given":"Tiffany","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4495-7245","authenticated-orcid":true,"given":"Laura","family":"Matrajt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"issue":"6","key":"pntd.0010358.ref001","first-page":"1","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"M Ali","year":"2015","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"34","key":"pntd.0010358.ref002","first-page":"477","article-title":"Cholera vaccines: WHO position paper\u2014August 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Weekly Epidemiological Record"},{"key":"pntd.0010358.ref003","doi-asserted-by":"crossref","first-page":"A132","DOI":"10.1016\/j.vaccine.2019.08.086","article-title":"Global oral cholera vaccine use, 2013\u20132018","volume":"38","author":"L Pezzoli","year":"2020","journal-title":"Vaccine"},{"issue":"12","key":"pntd.0010358.ref004","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: A cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"SK Bhattacharya","year":"2013","journal-title":"The Lancet Infectious Diseases"},{"issue":"18","key":"pntd.0010358.ref005","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh","volume":"374","author":"F Qadri","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"pntd.0010358.ref006","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1473-3099(18)30108-7","article-title":"Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial","volume":"18","author":"F Qadri","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"issue":"10","key":"pntd.0010358.ref007","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: A systematic review and meta-analysis","volume":"17","author":"Q Bi","year":"2017","journal-title":"The Lancet Infectious Diseases"},{"issue":"9","key":"pntd.0010358.ref008","doi-asserted-by":"crossref","first-page":"e1028","DOI":"10.1016\/S2214-109X(18)30284-5","article-title":"Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study","volume":"6","author":"MF Franke","year":"2018","journal-title":"The Lancet Global Health"},{"issue":"6","key":"pntd.0010358.ref009","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/jir416","article-title":"Natural cholera infection-derived immunity in an endemic setting","volume":"204","author":"M Ali","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"pntd.0010358.ref010","doi-asserted-by":"crossref","first-page":"e0009383","DOI":"10.1371\/journal.pntd.0009383","article-title":"Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review","volume":"15","author":"T Leung","year":"2021","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"2","key":"pntd.0010358.ref011","article-title":"The high burden of cholera in children: Comparison of incidence from endemic areas in Asia and Africa","volume":"2","author":"JL Deen","year":"2008","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"1","key":"pntd.0010358.ref012","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.vaccine.2015.10.112","article-title":"Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand","volume":"34","author":"CR Phares","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"pntd.0010358.ref013","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: Findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"AM Khatib","year":"2012","journal-title":"The Lancet Infectious Diseases"},{"issue":"8","key":"pntd.0010358.ref014","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"MES Lucas","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"October 2017","key":"pntd.0010358.ref015","doi-asserted-by":"crossref","first-page":"A141","DOI":"10.1016\/j.vaccine.2020.01.015","article-title":"Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017","volume":"38","author":"M Lubogo","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"pntd.0010358.ref016","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1056\/NEJMc1711583","article-title":"Single-dose cholera vaccine in response to an outbreak in Zambia","volume":"378","author":"E Ferreras","year":"2018","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"pntd.0010358.ref017","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2471\/BLT.16.189241","article-title":"Implementation research: Reactive mass vaccination with single-dose oral cholera vaccine, Zambia","volume":"96","author":"M Poncin","year":"2018","journal-title":"Bulletin of the World Health Organization"},{"issue":"11","key":"pntd.0010358.ref018","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1016\/S2214-109X(16)30211-X","article-title":"Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study","volume":"4","author":"AS Azman","year":"2016","journal-title":"The Lancet Global Health"},{"issue":"2","key":"pntd.0010358.ref019","first-page":"1","article-title":"Prolonging herd immunity to cholera via vaccination: Accounting for human mobility and waning vaccine effects","volume":"12","author":"CM Peak","year":"2018","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"1","key":"pntd.0010358.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13031-020-00295-9","article-title":"Infectious disease outbreaks among forcibly displaced persons: An analysis of ProMED reports 1996-2016","volume":"14","author":"AN Desai","year":"2020","journal-title":"Conflict and Health"},{"issue":"5","key":"pntd.0010358.ref021","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cmi.2017.03.012","article-title":"Migration and infectious diseases","volume":"23","author":"F Castelli","year":"2017","journal-title":"Clinical Microbiology and Infection"},{"issue":"7051","key":"pntd.0010358.ref022","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature03820","article-title":"Refractory periods and climate forcing in cholera dynamics","volume":"436","author":"K Koelle","year":"2005","journal-title":"Nature"},{"issue":"17","key":"pntd.0010358.ref023","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1073\/pnas.1617218114","article-title":"El Ni\u00f1o and the shifting geography of cholera in Africa","volume":"114","author":"SM Moore","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"pntd.0010358.ref024","first-page":"117","article-title":"Cholera outbreaks in Africa","volume":"379","author":"MA Mengel","year":"2014","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"7","key":"pntd.0010358.ref025","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/infdis\/jiy283","article-title":"Micro-hotspots of risk in urban cholera epidemics","volume":"218","author":"AS Azman","year":"2018","journal-title":"Journal of Infectious Diseases"},{"key":"pntd.0010358.ref026","unstructured":"Population Pyramid. Population of Chad 2011; 2021. Available from: https:\/\/www.populationpyramid.net\/chad\/2011\/."},{"issue":"3","key":"pntd.0010358.ref027","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1469-0691.2012.03763.x","article-title":"Cholera epidemics in 2010: Respective roles of environment, strain changes, and human-driven dissemination","volume":"18","author":"R Piarroux","year":"2012","journal-title":"Clinical Microbiology and Infection"},{"key":"pntd.0010358.ref028","unstructured":"M\u00e9decins Sans Fronti\u00e8res. Chad\u2014Preventing another cholera epidemic; 2012. Available from: https:\/\/www.msf.org\/chad-preventing-another-cholera-epidemic."},{"issue":"2","key":"pntd.0010358.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002509","article-title":"The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study","volume":"15","author":"F Finger","year":"2018","journal-title":"PLoS Medicine"},{"issue":"12","key":"pntd.0010358.ref030","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1371\/journal.pntd.0005210","article-title":"Use of oral cholera vaccine and knowledge, attitudes, and practices regarding safe water, sanitation and hygiene in a long-standing refugee camp, Thailand, 2012-2014","volume":"10","author":"HM Scobie","year":"2016","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"1","key":"pntd.0010358.ref031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4688-6","article-title":"Comparing alternative cholera vaccination strategies in Maela refugee camp: Using a transmission model in public health practice","volume":"19","author":"J Havumaki","year":"2019","journal-title":"BMC Infectious Diseases"},{"key":"pntd.0010358.ref032","doi-asserted-by":"crossref","first-page":"e1081","DOI":"10.1016\/S2214-109X(20)30310-7","article-title":"Achieving coordinated national immunity and cholera elimination in Haiti through vaccination","volume":"8","author":"EC Lee","year":"2020","journal-title":"Lancet Global Health"},{"issue":"1","key":"pntd.0010358.ref033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJMp1012997","article-title":"Responding to cholera in post-earthquake Haiti","volume":"364","author":"DA Walton","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"pntd.0010358.ref034","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1204927","article-title":"Cholera surveillance during the Haiti epidemic \u2014 The first 2 years","volume":"368","author":"EJ Barzilay","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"October","key":"pntd.0010358.ref035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/oxfordjournals.aje.a115884","article-title":"Direct and indirect effects in vaccine efficacy and effectiveness","volume":"133","author":"ME Halloran","year":"1991","journal-title":"American Journal of Epidemiology"},{"issue":"6","key":"pntd.0010358.ref036","doi-asserted-by":"crossref","first-page":"eabf1374","DOI":"10.1126\/sciadv.abf1374","article-title":"Vaccine optimization for COVID-19: Who to vaccinate first?","volume":"7","author":"L Matrajt","year":"2021","journal-title":"Science Advances"},{"issue":"3449","key":"pntd.0010358.ref037","article-title":"Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination","volume":"12","author":"L Matrajt","year":"2021","journal-title":"Nature Communications"},{"issue":"8","key":"pntd.0010358.ref038","doi-asserted-by":"crossref","first-page":"e1001867","DOI":"10.1371\/journal.pmed.1001867","article-title":"The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings: A modeling study","volume":"12","author":"AS Azman","year":"2015","journal-title":"PLoS Medicine"},{"issue":"11","key":"pntd.0010358.ref039","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"C Troeger","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"issue":"11","key":"pntd.0010358.ref040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013767","article-title":"Optimizing vaccine allocation at different points in time during an epidemic","volume":"5","author":"L Matrajt","year":"2010","journal-title":"PLoS ONE"},{"issue":"5948","key":"pntd.0010358.ref041","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1175570","article-title":"Optimizing influenza vaccine distribution","volume":"325","author":"J Medlock","year":"2009","journal-title":"Science"},{"issue":"29-30","key":"pntd.0010358.ref042","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.vaccine.2008.04.043","article-title":"Optimal allocation of pandemic influenza vaccine depends on age, risk and timing","volume":"26","author":"SD Mylius","year":"2008","journal-title":"Vaccine"},{"key":"pntd.0010358.ref043","first-page":"1","article-title":"Refugee Settlements and Cholera Risks in Uganda, 2016\u20142019","author":"G Bwire","year":"2021","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"pntd.0010358.ref044","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.epidem.2015.06.001","article-title":"One versus two doses: What is the best use of vaccine in an influenza pandemic?","volume":"13","author":"L Matrajt","year":"2015","journal-title":"Epidemics"},{"issue":"6","key":"pntd.0010358.ref045","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1371\/journal.pmed.0040218","article-title":"Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate","volume":"4","author":"S Riley","year":"2007","journal-title":"PLoS Medicine"},{"issue":"12","key":"pntd.0010358.ref046","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/aje\/kwp072","article-title":"Optimal dosing and dynamic distribution of vaccines in an influenza pandemic","volume":"169","author":"J Wood","year":"2009","journal-title":"American Journal of Epidemiology"},{"issue":"10","key":"pntd.0010358.ref047","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/jamapediatrics.2018.1960","article-title":"Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years","volume":"172","author":"C Troeger","year":"2018","journal-title":"JAMA Pediatrics"},{"issue":"S2","key":"pntd.0010358.ref048","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1093\/cid\/civ1209","article-title":"Impact of rotavirus vaccine introduction and vaccine effectiveness in the Republic of Moldova","volume":"62","author":"S Gheorghita","year":"2016","journal-title":"Clinical Infectious Diseases"},{"issue":"S2","key":"pntd.0010358.ref049","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1093\/cid\/civ1026","article-title":"Sustained effectiveness of rotavirus vaccine against very severe rotavirus disease through the second year of life, Bolivia 2013-2014","volume":"62","author":"KD Pringle","year":"2016","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"pntd.0010358.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofy292","article-title":"Effectiveness of the oral human attenuated rotavirus vaccine: A systematic review and meta-analysis\u20132006-2016","volume":"5","author":"C Willame","year":"2018","journal-title":"Open Forum Infectious Diseases"},{"key":"pntd.0010358.ref051","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1016\/j.vaccine.2019.07.078","article-title":"Epidemiology of cholera","volume":"38","author":"J Deen","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"pntd.0010358.ref052","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2471\/BLT.09.073460","article-title":"Cholera in India: An analysis of reports, 1997-2006","volume":"88","author":"S Kanungo","year":"2010","journal-title":"Bulletin of the World Health Organization"},{"issue":"Suppl 3","key":"pntd.0010358.ref053","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1093\/infdis\/jiy486","article-title":"Global cholera epidemiology: Opportunities to reduce the burden of cholera by 2030","volume":"218","author":"D Legros","year":"2018","journal-title":"Journal of Infectious Diseases"},{"key":"pntd.0010358.ref054","unstructured":"WHO Global Task Force on Cholera Control. Cholera outbreak: assessing the outbreak response and improving preparedness; 2004. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/43017."},{"issue":"480","key":"pntd.0010358.ref055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6242","article-title":"Estimating cholera incidence with cross-sectional serology","volume":"11","author":"AS Azman","year":"2019","journal-title":"Science Translational Medicine"},{"issue":"3","key":"pntd.0010358.ref056","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/S2214-109X(14)70368-7","article-title":"Effectiveness of reactive oral cholera vaccination in rural Haiti: A case-control study and bias-indicator analysis","volume":"3","author":"LC Ivers","year":"2015","journal-title":"The Lancet Global Health"},{"issue":"21","key":"pntd.0010358.ref057","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.vaccine.2015.03.073","article-title":"Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India","volume":"33","author":"TF Wierzba","year":"2015","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0010358","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T13:38:00Z","timestamp":1651498680000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010358"}},"subtitle":[],"editor":[{"given":"James Michael","family":"Fleckenstein","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010358","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.11.18.21266550","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]}}}